特殊血液凝固檢驗市場:開發平台報告(開發階段，市場區隔，地區·國家，法規途徑，主要企業)，2023年最新版

Special Coagulation Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

出版日期: 2023年06月30日 | 出版商:

GlobalData | 英文 46 Pages | 訂單完成後即時交付

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄圖表

本報告提供特殊血液凝固檢驗市場相關調查，提供產品概要與正在開發的開發中產品趨勢，參與企業的最近趨勢等資訊。

Abstract

GlobalData's Medical Devices sector report, "Special Coagulation Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Special Coagulation Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

These are reagents which are used to conduct special coagulation tests which provide quantitative determination of anticoagulant activities of heparin and thrombin formation.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Special Coagulation Tests under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Special Coagulation Tests and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Special Coagulation Tests under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Special Coagulation Tests Overview

3 Products under Development

3.1 Special Coagulation Tests - Pipeline Products by Stage of Development
3.2 Special Coagulation Tests - Pipeline Products by Territory
3.3 Special Coagulation Tests - Pipeline Products by Regulatory Path
3.4 Special Coagulation Tests - Pipeline Products by Estimated Approval Date

4 Special Coagulation Tests - Pipeline Products under Development by Companies

4.1 Special Coagulation Tests Companies - Pipeline Products by Stage of Development
4.2 Special Coagulation Tests - Pipeline Products by Stage of Development

5 Special Coagulation Tests Companies and Product Overview

5.1 Diagnostica Stago Inc Company Overview
- 5.1.1 Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Helena Laboratories Corp Company Overview
- 5.2.1 Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview
5.3 Instrumentation Laboratory Co Company Overview
- 5.3.1 Instrumentation Laboratory Co Pipeline Products & Ongoing Clinical Trials Overview
5.4 Massachusetts General Hospital Company Overview
- 5.4.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.5 Roche Diagnostics International Ltd Company Overview
- 5.5.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.6 Siemens Healthcare Diagnostics GmbH Company Overview
- 5.6.1 Siemens Healthcare Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.7 Siemens Healthcare Diagnostics Inc Company Overview
- 5.7.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 SQI Diagnostics Inc Company Overview
- 5.8.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Special Coagulation Tests- Recent Developments

6.1 May 30, 2023: SQI Diagnostics reports second quarter 2023 results
6.2 Aug 29, 2022: SQI Diagnostics Reports Third Quarter 2022 Results
6.3 Jul 25, 2022: Beckman Coulter partners with Mass General and BARDA to identify severe pediatric infections in emergency departments